Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist

被引：1
|
作者：
Shenoy, Niraj [1 ]
Pagliaro, Lance [1 ]
机构：
[1] Mayo Clin, Dept Med Oncol, 200 First St SW, Rochester, MN 55905 USA
来源：
EUROPEAN UROLOGY | 2018年 / 73卷 / 02期
关键词：
HIF1-ALPHA;
D O I：
10.1016/j.eururo.2017.10.007
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / 305
页数：4
相关论文
共 50 条
  • [41] Investigating the association of cytoplasmic and nuclear HIF-2 expression with cancer specific survival (CSS) in clear cell renal cell carcinoma
    Kroeger, Nils
    Seligson, David B.
    Signoretti, Sabina
    Yu, Hong
    Birkhaeuser, Frederic D.
    Magyar, Clara
    Huang, Jiaoti
    Riss, Joseph
    Kabbinavar, Fairooz F.
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [42] HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation
    Hughes, Michael D.
    Kapllani, Erilda
    Alexander, Ashlynn E.
    Burk, Robert D.
    Schoenfeld, Alan R.
    CANCER CELL INTERNATIONAL, 2007, 7 (1)
  • [43] HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation
    Michael D Hughes
    Erilda Kapllani
    Ashlynn E Alexander
    Robert D Burk
    Alan R Schoenfeld
    Cancer Cell International, 7
  • [44] A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
    Wallace, Eli M.
    Rizzi, James P.
    Han, Guangzhou
    Wehn, Paul M.
    Cao, Zhaodan
    Du, Xinlin
    Cheng, Tzuling
    Czerwinski, Robert M.
    Dixon, Darryl D.
    Goggin, Barry S.
    Grina, Jonas A.
    Halfmann, Megan M.
    Maddie, Melissa A.
    Olive, Sarah R.
    Schlachter, Stephen T.
    Tan, Huiling
    Wang, Bin
    Wang, Keshi
    Xie, Shanhai
    Xu, Rui
    Yang, Hanbiao
    Josey, John A.
    CANCER RESEARCH, 2016, 76 (18) : 5491 - 5500
  • [45] Selective Targeting HIF-2α for Treatment of Pulmonary Arterial Hypertension
    Dai, Zhiyu
    Zhu, Maggie M.
    Zhang, Xianming
    Tarjus, Antoine
    Zhao, Youyang
    FASEB JOURNAL, 2017, 31
  • [46] HIF-2α - a mediator of stem cell altruism?
    Cummins, Eoin P.
    STEM CELL RESEARCH & THERAPY, 2012, 3
  • [47] HIF-2α - a mediator of stem cell altruism?
    Eoin P Cummins
    Stem Cell Research & Therapy, 3
  • [48] HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma
    Lai, Xiang-Me
    Liu, Shu-Yu
    Tsai, Yi-Ta
    Sun, Guang-Huan
    Chang, Sun-Yran
    Huang, Shih-Ming
    Cha, Tai-Lung
    ONCOTARGET, 2017, 8 (30) : 49713 - 49724
  • [49] POOR PROGNOSIS AND ADVANCED CLINICOPATHOLOGICAL FEATURES OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC) ARE ASSOCIATED WITH CYTOPLASMIC SUBCELLULAR LOCALIZATION OF HIF-2α
    Kroeger, Nils
    Seligson, David
    Signoretti, Sabina
    Yu, Hong
    Logan, Joshua
    Birkhaeuser, Frederic
    Magyar, Clara
    Huang, Jiaoti
    Riss, Joseph
    Kabbinavar, Fairooz
    Belldegrun, Arie
    Pantuck, Allan
    JOURNAL OF UROLOGY, 2013, 189 (04): : E439 - E440
  • [50] Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
    Sourbier, Carole
    Srivastava, Gaurav
    Ghosh, Manik C.
    Ghosh, Sanchari
    Yang, Youfeng
    Gupta, Gopal
    DeGraff, William
    Krishna, Murali C.
    Mitchell, James B.
    Rouault, Tracey A.
    Linehan, W. Marston
    ONCOTARGET, 2012, 3 (11) : 1472 - 1482
12345